Dear Small Business Research Community,
I am pleased to announce two new Funding Opportunity Announcements (FOAS) that will be supported by funds provided to the NIH under the American Recovery & Reinvestment Act of 2009 (“Recovery Act” or “ARRA”).
|Announcement Number||Title||Issuing Organization||Release Date ||Receipt Date(s) |
|RFA-OD-09-008||Recovery Act Limited Competition: Biomedical Research, Development, and Growth to Spur the Acceleration of New Technologies (BRDG-SPAN) Pilot Program (RC3) ||NIH||06/02/2009||09/01/2009|
Recovery Act Limited Competition: Small Business Catalyst Awards for Accelerating Innovative Research (R43)
- Application due dates for these FOAs are September 1.
- Letters of Intent, though not required, are encouraged and are to be submitted by August 3, 2009.
- Note that one FOA is a pilot program and uses a new mechanism, called the RC1. This FOA aims to address the funding gap between promising research and transitioning to the market -- often called the “Valley of Death -- by contributing to the critical funding needed by applicants to pursue the next appropriate milestone(s) toward ultimate commercialization.
- The other FOA uses the SBIR Phase I (R43) activity code and encourages applications from small business concerns (particularly those without a history of NIH SBIR or STTR support) that propose to accelerate innovation through high risk, high reward R&D projects with commercial potential and that are relevant to the mission of the NIH.
I encourage you to review these FOAs and hope many of you will be able to take advantage of the opportunities.
Please feel free to contact the Institute/Center staff listed in the FOAs to discuss potential projects.
NOTE: IF YOU ARE NOT REGISTERED IN BOTH GRANTS.GOV AND eRA COMMONS, BE SURE TO START THE PROCESS NOW AS THESE REGISTRATIONS CAN TAKE AT LEAST 4 WEEKS AND ARE NECESSARY TO SUBMIT AN APPLICATION TO NIH.
Jo Anne Goodnight | NIH SBIR/STTR Program Coordinator | Office of Extramural Programs|